Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
6.15
-0.19 (-3.00%)
At close: Jul 30, 2025, 4:00 PM
6.00
-0.15 (-2.44%)
After-hours: Jul 30, 2025, 7:44 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $19.19 million as of July 30, 2025. Its market cap has decreased by -66.88% in one year.
Market Cap
19.19M
Enterprise Value
-18.05M
1-Year Change
-66.88%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $19.19M, a decrease of -97.99%. That is a compound annual growth rate of -51.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 19.78M | -43.52% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.58B |
| Johnson & Johnson | 405.32B |
| AbbVie | 336.11B |
| Novo Nordisk | 315.59B |
| UnitedHealth Group | 254.96B |
| Novartis AG | 225.74B |
| AstraZeneca | 225.08B |
| Abbott Laboratories | 220.16B |